Position in HRMY
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$2,551,830
-$239,702 QoQ
Shares Held
70,086
-29.7% QoQ
Ownership
0.120%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#97
of 328 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $2,077,377,990 across 384 Biotechnology names. HRMY ranks #97 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
706,968 | $351,172,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,637 | $216,142,034 | |
| 3 | MRNA |
Moderna, Inc.
|
2,165,414 | $151,643,941 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
2,225,190 | $78,749,472 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
227,786 | $68,570,419 | |
| 6 | INCY |
Incyte Corp
|
586,431 | $66,477,817 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
864,101 | $64,358,241 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
247,052 | $46,267,897 |
All Filings in HRMY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,551,830 | 70,086 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $2,791,532 | 99,662 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $5,782,885 | 154,540 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $4,907,773 | 178,076 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $5,752,747 | 182,049 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $6,815,232 | 205,340 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $6,875,151 | 199,801 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $7,113,720 | 177,843 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $4,887,057 | 161,984 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $5,491,337 | 163,530 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $5,394,713 | 167,019 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $802,273 | 24,482 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $1,148,916 | 32,649 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $716,535 | 21,946 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $1,562,690 | 28,361 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $1,161,945 | 26,235 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $988,566 | 20,270 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $1,224,617 | 25,172 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $901,494 | 21,142 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $112,345 | 2,931 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $60,581 | 2,146 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $29,570 | 895 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $47,681 | 1,319 | Shares | Defined | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||